Clinical Utility of Molecular Tests for Guiding Therapeutic Decisions in Bloodstream Staphylococcal Infections: A Meta-Analysis

Background: Treatment of bloodstream staphylococcal infections (BSI) necessitates the prompt initiation of appropriate antimicrobial agents and the rapid de-escalation of excessive broad-spectrum coverage to reduce the risk of mortality. We, therefore, aimed to demonstrate the diagnostic accuracy of...

Full description

Bibliographic Details
Main Authors: Ke Chen, Aijaz Ahmad Malik, Yun-Jian Sheng, Sarfraz Ahmed, Changfeng Sun, Cun-Liang Deng, Suvash Chandra Ojha
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.713447/full
_version_ 1818643689997598720
author Ke Chen
Ke Chen
Aijaz Ahmad Malik
Yun-Jian Sheng
Yun-Jian Sheng
Sarfraz Ahmed
Changfeng Sun
Changfeng Sun
Cun-Liang Deng
Suvash Chandra Ojha
Suvash Chandra Ojha
author_facet Ke Chen
Ke Chen
Aijaz Ahmad Malik
Yun-Jian Sheng
Yun-Jian Sheng
Sarfraz Ahmed
Changfeng Sun
Changfeng Sun
Cun-Liang Deng
Suvash Chandra Ojha
Suvash Chandra Ojha
author_sort Ke Chen
collection DOAJ
description Background: Treatment of bloodstream staphylococcal infections (BSI) necessitates the prompt initiation of appropriate antimicrobial agents and the rapid de-escalation of excessive broad-spectrum coverage to reduce the risk of mortality. We, therefore, aimed to demonstrate the diagnostic accuracy of nucleic acid amplification tests (NAAT) for the identification of methicillin-resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) in clinically suspected patients.Methods: Until November 23, 2020, databases including PubMed, Scopus, Embase, and Web of Science were scanned for eligible studies. A bivariate random-effects model was used for meta-analysis of the 33 included studies obtained from 1606 citations, and pooled summary estimates with 95% confidence intervals (CI) were generated.Results: Twenty-three studies (n = 8,547) assessed NAAT accuracy for MSSA detection, while three studies (n = 479) evaluated MRSA detection in adults. The pooled NAAT sensitivity and specificity for MRSA in adults was higher [sensitivity: 0.83 (95% CI 0.59–0.96), specificity: 0.99 (95% CI 0.98–1.0)] as compared to MSSA [sensitivity: 0.76 (95% CI 0.69–0.82), specificity: 0.98 (95% CI 0.98–0.99)]. Similarly, eight studies (n = 4,089) investigating MSSA in pediatric population reported higher NAAT accuracy [sensitivity: 0.89 (95% CI 0.76–0.96), specificity: 0.98 (95% CI 0.97–0.98)] compared to adults. Among NAA tests, SeptiFast (real-time PCR, commercial) was frequently applied, and its diagnostic accuracy corresponded well to the overall summary estimates. A meta-regression and subgroup analysis of study design, sample condition, and patient selection method could not explain the heterogeneity (P > 0.05) in the diagnostic efficiency.Conclusions: NAAT could be applied as the preferred initial tests for timely diagnosis and BSI management.
first_indexed 2024-12-17T00:02:57Z
format Article
id doaj.art-821cd221d760412c9b828d07967307f5
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-12-17T00:02:57Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-821cd221d760412c9b828d07967307f52022-12-21T22:11:02ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602021-08-01910.3389/fped.2021.713447713447Clinical Utility of Molecular Tests for Guiding Therapeutic Decisions in Bloodstream Staphylococcal Infections: A Meta-AnalysisKe Chen0Ke Chen1Aijaz Ahmad Malik2Yun-Jian Sheng3Yun-Jian Sheng4Sarfraz Ahmed5Changfeng Sun6Changfeng Sun7Cun-Liang Deng8Suvash Chandra Ojha9Suvash Chandra Ojha10Department of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSouthwest Medical University, Luzhou, ChinaFaculty of Medical Technology, Center of Data Mining and Biomedical Informatics, Mahidol University, Bangkok, ThailandDepartment of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSouthwest Medical University, Luzhou, ChinaDepartment of Basic Sciences, University of Veterinary and Animal Sciences Lahore, Narowal, PakistanDepartment of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSouthwest Medical University, Luzhou, ChinaDepartment of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaDepartment of Infectious Diseases, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaSouthwest Medical University, Luzhou, ChinaBackground: Treatment of bloodstream staphylococcal infections (BSI) necessitates the prompt initiation of appropriate antimicrobial agents and the rapid de-escalation of excessive broad-spectrum coverage to reduce the risk of mortality. We, therefore, aimed to demonstrate the diagnostic accuracy of nucleic acid amplification tests (NAAT) for the identification of methicillin-resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) in clinically suspected patients.Methods: Until November 23, 2020, databases including PubMed, Scopus, Embase, and Web of Science were scanned for eligible studies. A bivariate random-effects model was used for meta-analysis of the 33 included studies obtained from 1606 citations, and pooled summary estimates with 95% confidence intervals (CI) were generated.Results: Twenty-three studies (n = 8,547) assessed NAAT accuracy for MSSA detection, while three studies (n = 479) evaluated MRSA detection in adults. The pooled NAAT sensitivity and specificity for MRSA in adults was higher [sensitivity: 0.83 (95% CI 0.59–0.96), specificity: 0.99 (95% CI 0.98–1.0)] as compared to MSSA [sensitivity: 0.76 (95% CI 0.69–0.82), specificity: 0.98 (95% CI 0.98–0.99)]. Similarly, eight studies (n = 4,089) investigating MSSA in pediatric population reported higher NAAT accuracy [sensitivity: 0.89 (95% CI 0.76–0.96), specificity: 0.98 (95% CI 0.97–0.98)] compared to adults. Among NAA tests, SeptiFast (real-time PCR, commercial) was frequently applied, and its diagnostic accuracy corresponded well to the overall summary estimates. A meta-regression and subgroup analysis of study design, sample condition, and patient selection method could not explain the heterogeneity (P > 0.05) in the diagnostic efficiency.Conclusions: NAAT could be applied as the preferred initial tests for timely diagnosis and BSI management.https://www.frontiersin.org/articles/10.3389/fped.2021.713447/fullbloodstream infectionNAAT accuracystaphylococcal infectionspediatric populationmeta-analysis
spellingShingle Ke Chen
Ke Chen
Aijaz Ahmad Malik
Yun-Jian Sheng
Yun-Jian Sheng
Sarfraz Ahmed
Changfeng Sun
Changfeng Sun
Cun-Liang Deng
Suvash Chandra Ojha
Suvash Chandra Ojha
Clinical Utility of Molecular Tests for Guiding Therapeutic Decisions in Bloodstream Staphylococcal Infections: A Meta-Analysis
Frontiers in Pediatrics
bloodstream infection
NAAT accuracy
staphylococcal infections
pediatric population
meta-analysis
title Clinical Utility of Molecular Tests for Guiding Therapeutic Decisions in Bloodstream Staphylococcal Infections: A Meta-Analysis
title_full Clinical Utility of Molecular Tests for Guiding Therapeutic Decisions in Bloodstream Staphylococcal Infections: A Meta-Analysis
title_fullStr Clinical Utility of Molecular Tests for Guiding Therapeutic Decisions in Bloodstream Staphylococcal Infections: A Meta-Analysis
title_full_unstemmed Clinical Utility of Molecular Tests for Guiding Therapeutic Decisions in Bloodstream Staphylococcal Infections: A Meta-Analysis
title_short Clinical Utility of Molecular Tests for Guiding Therapeutic Decisions in Bloodstream Staphylococcal Infections: A Meta-Analysis
title_sort clinical utility of molecular tests for guiding therapeutic decisions in bloodstream staphylococcal infections a meta analysis
topic bloodstream infection
NAAT accuracy
staphylococcal infections
pediatric population
meta-analysis
url https://www.frontiersin.org/articles/10.3389/fped.2021.713447/full
work_keys_str_mv AT kechen clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis
AT kechen clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis
AT aijazahmadmalik clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis
AT yunjiansheng clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis
AT yunjiansheng clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis
AT sarfrazahmed clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis
AT changfengsun clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis
AT changfengsun clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis
AT cunliangdeng clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis
AT suvashchandraojha clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis
AT suvashchandraojha clinicalutilityofmoleculartestsforguidingtherapeuticdecisionsinbloodstreamstaphylococcalinfectionsametaanalysis